The use of antibiotics in food animals raises two connected public-policy concerns: preserving medicines that treat bacterial infections and preventing unsafe food residues. The objective is to reduce unnecessary use while maintaining access to appropriate veterinary treatment. Leaving sick animals untreated is not a sound strategy for animal welfare, farm livelihoods or public health.
Why animal antibiotic use matters for human health
Antibiotic exposure can favour bacteria able to survive that exposure. Resistant bacteria and resistance genes can spread through connected human, animal and environmental systems. Food production is one part of this network, alongside healthcare, community use and waste pathways.
The WHO’s 2017 guidance recommends ending routine use of medically important antibiotics for growth promotion and disease prevention in healthy animals without a diagnosed need. This is international public-health guidance. It should be distinguished from the specific legal controls applicable to a drug, species or product in India.
An important Indian example: the colistin prohibition
CDSCO’s notification register records S.O. 2607 of 19 July 2019 prohibiting colistin for food-producing animals, poultry, aquaculture and animal feed supplements under Section 26A of the Drugs and Cosmetics Act. The measure addressed manufacture, sale and distribution for these animal-related uses.
For examination purposes, remember the substance and scope together. This notification is not a blanket prohibition on every veterinary antibiotic. A discussion of regulation must distinguish targeted restrictions from prescription requirements, food-residue controls, responsible-use guidance and surveillance.
Residues and resistance are different problems
| Concept | Meaning | What an assessment needs |
|---|---|---|
| Drug residue | A drug or relevant breakdown product remaining in food after treatment | Appropriate chemical testing and the applicable food standard |
| Antimicrobial resistance | A microorganism’s ability to withstand a medicine that would ordinarily act against it | Microbiological testing and interpretation |
| Withdrawal period | The required interval after treatment before relevant animal products can enter the food chain | The authorised product instructions and veterinary guidance |
| Growth promotion | Use aimed at improving production rather than treating a diagnosed infection | Scrutiny of the purpose and necessity of antimicrobial use |
A sample with no detectable antibiotic residue does not prove that resistant bacteria are absent. Conversely, a residue result does not identify which organisms are resistant. These require different laboratory methods and different corrective actions.
How to reduce demand for unnecessary treatment
FAO emphasises good husbandry, suitable housing, clean water, hygiene, vaccination and biosecurity. These measures reduce the infections that lead to medicine use. They are especially important where repeated outbreaks make preventive antibiotic use appear cheaper than improving everyday farm conditions.
Consider an illustrative poultry unit facing recurrent illness. A useful response investigates ventilation, stocking conditions, water quality, movement of birds and diagnostic findings. Simply replacing one antibiotic with another can leave the cause untouched. Farm improvements should be accompanied by veterinary assessment, rather than a promise that one feed additive will remove every disease risk.
Small producers may struggle to obtain diagnostics or qualified advice quickly. Policy therefore needs affordable veterinary services and practical extension alongside enforcement. Otherwise, a stricter rule can coexist with informal sales and delayed treatment.
What responsible supply chains need
WOAH assigns responsibilities beyond the farm. Feed manufacturers must control contamination, follow applicable requirements and provide suitable labels. Distributors should maintain traceability, and veterinary oversight should guide appropriate treatment. Records of the product, animals treated and relevant dates make it possible to investigate a problem rather than rely on memory.
Food businesses can support these practices through clear procurement requirements and fair arrangements for producers. A buyer demanding safer production while refusing to cover any associated cost may encourage concealment rather than improvement. Monitoring should therefore examine incentives as well as paperwork.
Why surveillance must connect several kinds of information
A useful monitoring system compares antimicrobial sales or use with animal populations, production systems and resistance findings. A fall in total sales can reflect changes in livestock numbers; it does not automatically show better prescribing. Similarly, a collection of samples from suspected problem farms cannot be treated as a representative estimate for every farm.
Codex’s work on foodborne AMR supports risk analysis and coordinated monitoring across the food chain. India’s practical challenge is connecting drug controls, veterinary care, food testing and environmental management. The broader note on antibiotic resistance and One Health explains why these sectors must exchange evidence.
Questions for revision
1. Does antibiotic regulation mean refusing treatment to sick animals?
No. Appropriate veterinary treatment remains important. The focus is on unnecessary use, compliance with applicable restrictions and responsible administration.
2. Can residue testing alone measure AMR?
No. Chemical residues and resistant microorganisms are different testing targets. A complete food-safety approach needs both appropriate standards and microbiological evidence.
